SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-021077
Filing Date
2021-08-24
Accepted
2021-08-24 07:44:20
Documents
14
Period of Report
2021-08-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42328
2 ex99-1.htm EX-99.1 12682
3 ex99-1_001.jpg GRAPHIC 2911
  Complete submission text file 0001493152-21-021077.txt   235866

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ogen-20210823.xsd EX-101.SCH 3027
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ogen-20210823_lab.xml EX-101.LAB 34239
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ogen-20210823_pre.xml EX-101.PRE 22360
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3621
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32188 | Film No.: 211198475
SIC: 2834 Pharmaceutical Preparations